# Study to Assess Safety and Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in Participants With Schizophrenia

> clinical trial · VERIFIED · 2026-06-22

Status: COMPLETED · Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company · Condition: Schizophrenia

- Company: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Sector: psychiatry
- Primary source: https://clinicaltrials.gov/study/NCT06572449

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.